SHARE-BASED COMPENSATION (Tables)
|
6 Months Ended |
May 04, 2025 |
SHARE-BASED COMPENSATION [Abstract] |
|
Share-based Compensation Expenses |
The table below presents information on the Company’s share-based compensation expenses.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
May 4,
|
|
|
April 28,
|
|
|
May 4,
|
|
|
April 28,
|
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Expense reported in:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of goods sold
|
|
$
|
785
|
|
|
$
|
669
|
|
|
$ |
1,562 |
|
|
$ |
1,263 |
|
Selling, general, and administrative
|
|
|
2,288
|
|
|
|
2,987
|
|
|
|
4,556 |
|
|
|
4,737 |
|
Research and development
|
|
|
302
|
|
|
|
270
|
|
|
|
592 |
|
|
|
499 |
|
Total expense incurred
|
|
$
|
3,375
|
|
|
$
|
3,926
|
|
|
$ |
6,710 |
|
|
$ |
6,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expense by award type:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted stock awards
|
|
$
|
2,809
|
|
|
$
|
3,926
|
|
|
$ |
6,086 |
|
|
$ |
6,499 |
|
Restricted stock units
|
|
|
509 |
|
|
|
- |
|
|
|
509 |
|
|
|
- |
|
Employee stock purchase plan
|
|
|
57
|
|
|
|
-
|
|
|
|
115 |
|
|
|
- |
|
Total expense incurred
|
|
$
|
3,375
|
|
|
$
|
3,926
|
|
|
$ |
6,710 |
|
|
$ |
6,499 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax benefits on share-based compensation
|
|
$
|
406
|
|
|
$
|
323
|
|
|
$ |
852 |
|
|
$ |
421 |
|
|
Restricted Stock Awards Activity |
The table below presents information on
the Company’s restricted stock awards.
|
|
Three Months Ended
|
|
|
Six Months Ended |
|
|
|
|
|
|
April 28,
|
|
|
May 4,
|
|
|
April 28,
|
|
|
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024 |
|
Number of shares granted in period
|
|
|
237,738
|
|
|
|
-
|
|
|
|
583,238 |
|
|
|
825,050 |
|
Weighted-average grant-date fair value of awards (in dollars
per share)
|
|
$
|
21.28
|
|
|
$
|
-
|
|
|
$ |
23.42 |
|
|
$ |
29.77 |
|
Compensation cost not yet recognized
|
|
$
|
27,028
|
|
|
$
|
28,695
|
|
|
$ |
27,028 |
|
|
$ |
28,695 |
|
Weighted-average amortization period for cost not yet
recognized (in years)
|
|
|
3.0
|
|
|
|
3.1
|
|
|
|
3.0 |
|
|
|
3.1 |
|
Shares outstanding at balance sheet date
|
|
|
1,439,672
|
|
|
|
1,560,540
|
|
|
|
1,439,672 |
|
|
|
1,560,540 |
|
|
Restricted Stock Units Activity |
The table below presents information on the Company’s restricted stock awards.
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
May 4,
|
|
|
April 28,
|
|
|
May 4,
|
|
|
April 28,
|
|
|
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
Number of units granted in period
|
|
|
52,836
|
|
|
|
-
|
|
|
|
52,836
|
|
|
|
-
|
|
Weighted-average grant-date fair value of awards (in dollars per share)
|
|
$
|
22.52
|
|
|
$
|
-
|
|
|
$
|
22.52
|
|
|
$
|
-
|
|
Compensation cost not yet recognized
|
|
$
|
681
|
|
|
$
|
-
|
|
|
$
|
681
|
|
|
$
|
-
|
|
Weighted-average amortization period for cost not yet recognized (in years)
|
|
|
0.8
|
|
|
|
-
|
|
|
|
0.8
|
|
|
|
-
|
|
Restricted stock units outstanding at balance sheet date
|
|
|
33,966
|
|
|
|
-
|
|
|
|
33,966
|
|
|
|
-
|
|
|
Stock Options Activity |
The table below presents information on the Company’s stock options.
|
|
Three Months Ended
|
|
|
Six Months Ended |
|
|
|
May 4,
|
|
|
April 28,
|
|
|
May 4,
|
|
|
April 28,
|
|
|
|
2025 |
|
|
2024 |
|
|
2025 |
|
|
2024 |
|
Number of options granted in period
|
|
|
-
|
|
|
|
-
|
|
|
|
- |
|
|
|
- |
|
Cash received from options exercised
|
|
$
|
26
|
|
|
$
|
119
|
|
|
$ |
1,298 |
|
|
$ |
1,055 |
|
Compensation cost not yet recognized
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$ |
- |
|
|
$ |
- |
|
Weighted-average amortization period for cost not yet recognized (in years)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
- |
|
|
Outstanding and Exercisable Option |
Information regarding outstanding and exercisable option awards
as of May 4, 2025, is presented below.
Options
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Weighted
Average
Remaining
Contractual
Life (in years)
|
|
|
Aggregate
Intrinsic
Value
|
|
Outstanding and exercisable at May 4, 2025
|
|
|
148,075
|
|
|
$
|
10.72
|
|
|
|
1.80
|
|
|
$
|
1,259
|
|
|